FDA: J&J delayed reporting insulin pump problems

TRENTON, New Jersey (AP) — The widening quality problems at health giant Johnson & Johnson have former regulators and analysts mystified, as yet another J&J business — at least the seventh — has come under scrutiny.

The lapses are hard to reconcile with J&J's image: It's the company that decades ago set the textbook standard for protecting public safety with a nationwide recall of Tylenol bottles that an outsider had poisoned. And its executives still cite the corporate credo, prominently displayed at headquarters, stressing the company's responsibility to the doctors, patients and parents who use its products.

This time it's the unit that makes insulin pumps for …